#Atrial_Fibrillation hashtag - Bluesky

@newsen.bsky.social

3 days ago

Volta Medical Sets the Stage for Innovation at HRS 2026 Conference in Chicago Volta Medical reveals groundbreaking AI solutions for complex atrial fibrillation at the upcoming Heart Rhythm Society 2026 in Chicago.

Volta Medical Sets the Stage for Innovation at HRS 2026 Conference in Chicago #United_States #Chicago #AI_Solutions #Atrial_Fibrillation #Volta_Medical

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

New Insights from Korea University on Liver Disease Impacting Heart Failure Risk in Older Adults with Atrial Fibrillation A Korea University study reveals that various liver metabolic diseases significantly heighten heart failure risk in older adults with atrial fibrillation, revealing a vital connection.

New Insights from Korea University on Liver Disease Impacting Heart Failure Risk in Older Adults with Atrial Fibrillation #Korea_University #Liver_Disease #Atrial_Fibrillation

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

1 month ago

XYRA's New Patent Offers Hope for Patients at Risk of Heart Failure and Strokes XYRA LLC has obtained a new US patent for a treatment aimed at reducing atrial fibrillations, potentially transforming heart failure and stroke risk management.

XYRA's New Patent Offers Hope for Patients at Risk of Heart Failure and Strokes #USA #Atrial_Fibrillation #Los_Altos #Budiodarone #XYRA_LLC

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

2 months ago

Volta Medical's RESTART Study Unveils Promising AI Solutions for Atrial Fibrillation Management Volta Medical's RESTART study reveals a significant breakthrough in AI solutions for recurrent atrial fibrillation, highlighting improved patient outcomes.

Volta Medical's RESTART Study Unveils Promising AI Solutions for Atrial Fibrillation Management #France #Atrial_Fibrillation #Marseille #Volta_Medical #RESTART_Study

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

2 months ago

Volta Medical's RESTART Trial Reveals Breakthrough AI Treatment for Atrial Fibrillation Volta Medical's RESTART trial has unveiled promising results for an AI treatment targeting recurrent atrial fibrillation, showing significant patient benefits and potential for improved care.

Volta Medical's RESTART Trial Reveals Breakthrough AI Treatment for Atrial Fibrillation #France #AI_Solutions #Atrial_Fibrillation #Marseille #Volta_Medical

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

2 months ago

Volta Medical's RESTART Trial Offers Hope for Treating Recurrent Atrial Fibrillation with Innovative AI Solutions The RESTART trial by Volta Medical reveals groundbreaking results in using AI to treat recurrent atrial fibrillation, showcasing a high success rate and improved patient quality of life.

Volta Medical's RESTART Trial Offers Hope for Treating Recurrent Atrial Fibrillation with Innovative AI Solutions #USA #Boston #Atrial_Fibrillation #Volta_Medical #AF-Xplorer

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

2 months ago

Promising Results from Volta Medical's RESTART Trial on AI for Atrial Fibrillation Treatment Volta Medical's recent trial reveals inspiring outcomes for using AI in treating recurrent atrial fibrillation, marking a significant step forward in cardiac care.

Promising Results from Volta Medical's RESTART Trial on AI for Atrial Fibrillation Treatment #USA #AI_Solutions #Boston #Atrial_Fibrillation #Volta_Medical

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

2 months ago

Promising AI Solutions from Volta Medical Revolutionize Atrial Fibrillation Treatment Volta Medical's RESTART trial provides significant advancements in treating recurrent atrial fibrillation with innovative AI solutions, promising improved patient outcomes.

Promising AI Solutions from Volta Medical Revolutionize Atrial Fibrillation Treatment #France #AI_Solutions #Atrial_Fibrillation #Marseille #Volta_Medical

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

2 months ago

Abbott's TactiFlex™ Duo Catheter Receives CE Mark for Atrial Fibrillation Treatment in Europe Abbott has obtained CE Mark certification for its TactiFlex™ Duo Ablation Catheter, designed to treat atrial fibrillation patients, enhancing their treatment options.

Abbott's TactiFlex™ Duo Catheter Receives CE Mark for Atrial Fibrillation Treatment in Europe #None #Abbott #Atrial_Fibrillation #TactiFlex™_Duo

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

3 months ago

HUYABIO International Reports Promising Phase 1 Results for HBI-3000 in Atrial Fibrillation Treatment HUYABIO International's newly developed drug HBI-3000 shows positive Phase 1 clinical results, offering hope for safer atrial fibrillation treatment with lower risks.

HUYABIO International Reports Promising Phase 1 Results for HBI-3000 in Atrial Fibrillation Treatment #United_States #San_Diego #Atrial_Fibrillation #HBI-3000 #sulcardine

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

3 months ago

Acesion Pharma Launches Phase 2 Trials for New AF Treatment AP31969 Acesion Pharma has initiated Phase 2 trials for AP31969, a promising treatment for atrial fibrillation, with a focus on safety and efficacy.

Acesion Pharma Launches Phase 2 Trials for New AF Treatment AP31969 #Denmark #Copenhagen #Atrial_Fibrillation #Acesion_Pharma #AP31969

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

3 months ago

Abbott's Innovative Volt Pulsed Field Ablation System Gains FDA Approval for Atrial Fibrillation Treatment Abbott's Volt™ Pulsed Field Ablation System has received FDA approval, presenting a new treatment option for atrial fibrillation, facilitating better outcomes for patients.

Abbott's Innovative Volt Pulsed Field Ablation System Gains FDA Approval for Atrial Fibrillation Treatment #USA #Abbott #Abbott_Park #Atrial_Fibrillation #Volt_PFA_System

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

5 months ago

Volta Medical Unveils AF-Xplorer II in the U.S.: Transforming Atrial Fibrillation Treatment with Cutting-Edge AI Volta Medical has launched the AF-Xplorer II in the U.S., a groundbreaking AI system that significantly enhances the treatment of complex atrial fibrillation, improving patient care.

Volta Medical Unveils AF-Xplorer II in the U.S.: Transforming Atrial Fibrillation Treatment with Cutting-Edge AI #USA #Atrial_Fibrillation #Marseille #Volta_Medical #AF-Xplorer_II

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

5 months ago

Celebrating the Opening of Benesse's New Rehabilitation Home in Nakano with a Medical Seminar Benesse Style Care is set to unveil their new rehabilitation home in Nakano with a special seminar addressing atrial fibrillation risks and management.

Celebrating the Opening of Benesse's New Rehabilitation Home in Nakano with a Medical Seminar #Japan #Tokyo #Atrial_Fibrillation #Nakano #Benesse

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

6 months ago

Argá Medtech Launches COHERENT-AF IDE Clinical Trial to Treat Atrial Fibrillation Argá Medtech has initiated the COHERENT-AF IDE trial to evaluate its innovative CSE system for treating atrial fibrillation. This approach aims for FDA approval.

Argá Medtech Launches COHERENT-AF IDE Clinical Trial to Treat Atrial Fibrillation #Switzerland #Lausanne #Atrial_Fibrillation #CSE_System #Argá_Medtech

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

7 months ago

Boston Scientific's FARAPULSE™ System Gains Approval for Persistent Atrial Fibrillation Treatment Boston Scientific Japan has announced the approval of the FARAPULSE™ PFA system to treat persistent atrial fibrillation, expanding options for patients.

Boston Scientific's FARAPULSE™ System Gains Approval for Persistent Atrial Fibrillation Treatment #Japan #Tokyo #Boston_Scientific #Atrial_Fibrillation #FARAPULSE

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

7 months ago

Join the 2025 Afib Awareness Campaign to Help Save Lives and Empower Patients The 2025 campaign seeks to raise atrial fibrillation awareness, encouraging early diagnosis and lifestyle changes to prevent severe complications.

Join the 2025 Afib Awareness Campaign to Help Save Lives and Empower Patients #USA #Dallas #Atrial_Fibrillation #Heart_Health #StopAfib

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

8 months ago

Kyorin University Launches Study on Atrial Fibrillation with Apple Watch Technology A new research study at Kyorin University explores the impact of Apple Watch on monitoring atrial fibrillation patients' exercise, sleep, and quality of life.

Kyorin University Launches Study on Atrial Fibrillation with Apple Watch Technology #Japan #Apple_Watch #Atrial_Fibrillation #Mitaka #Kyorin_University

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

8 months ago

DeepQure's HyperQure™ Receives Approval for AF Clinical Trials in South Korea DeepQure's innovative HyperQure™ system has secured approval for clinical trials in South Korea to treat atrial fibrillation. This marks a significant step in cardiovascular technology.

DeepQure's HyperQure™ Receives Approval for AF Clinical Trials in South Korea #South_Korea #Seoul #Atrial_Fibrillation #DeepQure #HyperQure

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

9 months ago

Boston Scientific's FARAPULSE™ System Receives FDA Approval for Expanded Use in Atrial Fibrillation Treatment Boston Scientific's FARAPULSE™ Pulsed Field Ablation System has gained FDA approval for expanded use in treating persistent atrial fibrillation, improving patient care.

Boston Scientific's FARAPULSE™ System Receives FDA Approval for Expanded Use in Atrial Fibrillation Treatment #None #Marlborough #Boston_Scientific #Atrial_Fibrillation #FARAPULSE™

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

11 months ago

EnChannel Medical Secures $82.2M in Series B Funding to Enhance Atrial Fibrillation Treatment Innovations EnChannel Medical has successfully raised $82.2 million in an oversubscribed Series B financing to propel advancements in atrial fibrillation therapies and mapping technology.

EnChannel Medical Secures $82.2M in Series B Funding to Enhance Atrial Fibrillation Treatment Innovations #China #Guangzhou #Atrial_Fibrillation #Series_B_Funding #EnChannel_Medical

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

11 months ago

Medtronic's Affera™ Technology Shows Promising Outcomes for Atrial Fibrillation Treatments at Heart Rhythm Society Medtronic's Affera™ systems are delivering groundbreaking clinical results for atrial fibrillation patients, showcasing advanced ablation technologies and their remarkable efficacy.

Medtronic's Affera™ Technology Shows Promising Outcomes for Atrial Fibrillation Treatments at Heart Rhythm Society #Ireland #Atrial_Fibrillation #Medtronic #Galway #Affera

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

11 months ago

Johnson & Johnson MedTech Shares Promising 3-Month Results from Omny-IRE Trial at HRS 2025 At the 2025 Heart Rhythm Society meeting, J&J MedTech presented early data from the Omny-IRE trial, showcasing effective atrial fibrillation treatments with the OMNYPULSE™ platform.

Johnson & Johnson MedTech Shares Promising 3-Month Results from Omny-IRE Trial at HRS 2025 #United_States #Johnson_&_Johnson #Irvine #Atrial_Fibrillation #OMNYPULSE™

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

11 months ago

Boston Scientific Reports Positive Outcomes from Second Phase of ADVANTAGE AF Study with FARAPULSE System Boston Scientific releases promising results from the ADVANTAGE AF trial, highlighting the effectiveness and safety of the FARAPULSE™ system for atrial fibrillation treatment.

Boston Scientific Reports Positive Outcomes from Second Phase of ADVANTAGE AF Study with FARAPULSE System #USA #Marlborough #Boston_Scientific #Atrial_Fibrillation #FARAPULSE

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

11 months ago

HUYABIO International Unveils Positive Results from HBI-3000 Phase 2A Clinical Trial for Acute Atrial Fibrillation Discover how HUYABIO International's HBI-3000 offers promising clinical results for atrial fibrillation treatment, enhancing patient care.

HUYABIO International Unveils Positive Results from HBI-3000 Phase 2A Clinical Trial for Acute Atrial Fibrillation #United_States #San_Diego #Atrial_Fibrillation #HUYABIO #HBI-3000

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

11 months ago